SPEARHEAD-1 trial design: A phase 2, single arm, open-label clinical trial of ADP-A2M4 SPEAR T-cells in patients with advanced synovial sarcoma or myxoid/round cell liposarcoma

Araujo, D; Blay, JY; Strauss, S; Valverde, C; Van Winkle, E; Iyengar, M; Amado, R

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019; 7 ():